What is the serial number for GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP?

The USPTO serial number for GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP is 79238024.

What is the registration number for GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP?

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP is registered under USPTO registration number 5809123.

GAR

USPTO Trademark Record

ABANDONED

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP

Q: Who owns the GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP trademark?

The GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP trademark is owned by GARDP Foundation.

Q: What class is the GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP trademark registered in?

The GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 036 (Insurance, financial & real estate services), Class 041 (Education & entertainment services), Class 042 (Scientific, technology & SaaS services).

SN 79238024·Reg 5809123·Filed Apr 17, 2018

Owner GARDP Foundation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Financial, monetary and banking services; insurance services; real estate services.; Education; providing of training; entertainment; sporting and cultural activities.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP (Serial No. 79238024), Registration No. 5809123, is a abandoned US trademark filed on Apr 17, 2018 by GARDP Foundation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 036 (Insurance, financial & real estate services), Class 041 (Education & entertainment services), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP (Reg. #5809123) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 036 (Insurance, financial & real estate services), Class 041 (Education & entertainment services) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Apr 17, 2018

SERIAL

79238024

REG#

5809123

REGISTERED

Jul 23, 2019

Owner

Applicant

GARDP Foundation

Entity

Not Provided

Address

Chemin Louis-Dunant 15, CH-1202 Genève

Country

Attorney

Law firm

Glenn A. Gundersen Dechert LLP

Address

2929 Arch Street, Cira Centre, Philadelphia, PA 19104-2808, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateApr 17, 2018

Serial Number79238024

Registration No.5809123

Registration DateJul 23, 2019

Status DateFeb 06, 2026

Published for OppositionMay 07, 2019

Mark TypeDesign with words

Status DescriptionDead and cancelled, Section 71

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 036Insurance, financial & real estate services

US codes: 100, 101, 102

Financial, monetary and banking services; insurance services; real estate services.

Class 041Education & entertainment services

US codes: 100, 101, 107

Education; providing of training; entertainment; sporting and cultural activities.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

31 events

CANCELLED SECTION 71

Feb 06, 2026

CANCELLED SECTION 71

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jul 23, 2024

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Jan 10, 2020

FINAL DECISION TRANSACTION PROCESSED BY IB

GENERIC MADRID TRANSACTION CREATED

Nov 14, 2019

GENERIC MADRID TRANSACTION CREATED

GENERIC MADRID TRANSACTION SENT TO IB

Nov 14, 2019

GENERIC MADRID TRANSACTION SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 23, 2019

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jul 23, 2019

REGISTERED-PRINCIPAL REGISTER

CHANGE OF OWNER RECEIVED FROM IB

Jul 05, 2019

CHANGE OF OWNER RECEIVED FROM IB

PUBLISHED FOR OPPOSITION

May 07, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 07, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

May 03, 2019

NOTIFICATION PROCESSED BY IB

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Apr 17, 2019

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 17, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 17, 2019

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

EXAMINERS AMENDMENT -WRITTEN

Mar 12, 2019

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 12, 2019

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 12, 2019

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 12, 2019

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 12, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 15, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 15, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 15, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Sep 08, 2018

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Aug 23, 2018

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Aug 23, 2018

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 14, 2018

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Aug 13, 2018

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

Aug 11, 2018

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 07, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Aug 07, 2018

ASSIGNED TO EXAMINER

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 02, 2018

SN ASSIGNED FOR SECT 66A APPL FROM IB

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by GARDP Foundation

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Resources

Company